Brief: Inovio Reports First Quarter 2026 Financial Results And Recent Business Highlights
13/05/2026 22:53
May 13 (Reuters) - Inovio Pharmaceuticals Inc INO.O: INOVIO REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS INOVIO PHARMACEUTICALS INC - FDA ACTIVELY REVIEWING INO-3107 BLA UNDER ACCELERATED APPROVAL WITH PDUFA DATE OCT 30, 2026 INOVIO PHARMACEUTICALS INC - ANTICIPATES CASH WILL FUND OPERATIONS INTO Q1 2027, BEYOND PDUFA DATE Source text: ID:nPn2Fl4K7a Further company coverage: INO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Inovio Pharmaceuticals
See all newsBrief: Inovio Announces Favorable Judgment In Litigation With Vgxi, Inc. And Geneone Life Science
U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan Holdings
Inovio Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Inovio Q2 net loss narrows on warrant gain, lower costs
Brief: Inovio Pharmaceuticals Q2 Operating Expenses USD 18.6 Million